Search Results
Prescient Therapeutics (ASX: PTX) Investor Briefing - 28 January 2020
Prescient Therapeutics (ASX: PTX) Webcast | SNN Network
Prescient Therapeutics (ASX: PTX) Investor Briefing - 26 November 2019
Prescient Therapeutics is developing novel personalised therapies against a range of cancers
Steven Yatomi-Clarke from Prescient Therapeutics (ASX:PTX) | Switzer Small and Micro Cap Day
ShareCafe 'Hidden Gems' Webinar - Prescient Therapeutics ASX:PTX
Prescient Therapeutics Interview with Finance News Network
Prescient Therapeutics in the burgeoning field of precision cancer medicines | No.2
Prescient Therapeutics advances innovative cancer therapies following successful FY 2021
Prescient Therapeutics (ASX: PTX): Steven Yatomi-Clarke, Managing Director & Chief Executive Officer
Antisense Therapeutics Presentation - NWR Virtual Small Cap Investor Conference, Series 2
Chimeric Therapeutics Presentation - 2021 NWR Virtual Investor Conference
